Abstract
The objective of this study was to evaluate the extent of gabapentin misuse in a dually diagnosed correctional population, and to evaluate if this abuse is specific to the presence of an opioid use disorder (OUD). Two-hundred and fifty former inmates, living in a correctional community center, who were referred for a psychiatric evaluation, were asked, through a brief written questionnaire, whether or not they used the following drugs for non-medical use in the past: opiates, gabapentin, buproprion, quetiapine, and fluoxetine. The average age of this population was 37.2 ± 12.1 years (n = 250). Sixty-four percent were male, 72 % were white, 27 % were black, and 1 % was Hispanic. All patients had substance use disorders, the large majority (72 %) to more than one substance. Fifty-eight percent had an opioid use disorder, again mostly in combination with other drugs and/or alcohol. Depressive disorders and attention deficit hyperactivity disorder were the most common psychiatric conditions. Sixty-two percent of patients reported prescription drug misuse of any kind. As expected, a high percent (55 %) reported opiate misuse. No patient reported fluoxetine misuse. Sixteen percent reported having misused gabapentin in the past. Of pa...Continue Reading
References
May 8, 1999·Epilepsy Research·L RochaN T Maidment
Aug 10, 1999·Journal of Clinical Psychopharmacology·A C PandeS M Sutherland
Jan 5, 2000·The American Journal of Psychiatry·M Karam-Hage, K J Brower
Aug 5, 2000·Journal of Clinical Psychopharmacology·A C PandeT Shiovitz
Mar 16, 2001·Bipolar Disorders·A C PandeG Tsaroucha
Feb 21, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Vasilis BozikasAthanasios Karavatos
Sep 17, 2004·The American Journal on Addictions·Lawrence ReccoppaMichael Ware
Mar 17, 2006·Journal of American College Health : J of ACH·Sean Esteban McCabeCarol J Boyd
Mar 13, 2009·Drug and Alcohol Dependence·Sean Esteban McCabeChristian J Teter
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George F Koob, Nora D Volkow
Aug 8, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Blair H SmithJonathan Bannister
Jun 19, 2013·Journal of Clinical Psychopharmacology·Roy R Reeves, Mark E Ladner
Jun 22, 2013·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Wanda T HilliardAngela Koranek
Nov 7, 2013·European Addiction Research·Colin R W BairdLesley A Colvin
Feb 11, 2015·The Primary Care Companion to CNS Disorders·Roy R Reeves, Randy S Burke
Citations
Feb 2, 2017·Drugs·Kirk E EvoyStephen R Saklad
May 12, 2017·Pharmacoepidemiology and Drug Safety·Mance E ButtramZachary R Margolin
Jun 9, 2016·The Annals of Pharmacotherapy·Udo Bonnet, Norbert Scherbaum
Feb 28, 2018·Pharmacotherapy·Alyssa M PeckhamDavid A Sclar
Mar 27, 2018·Clinical Pharmacology in Drug Development·H Karl Greenblatt, David J Greenblatt
Mar 27, 2018·British Journal of Pharmacology·Rob HillGraeme Henderson
Mar 22, 2018·Archives of public health = Archives belges de santé publique·Luk Van BaelenLies Gremeaux
Feb 10, 2019·British Journal of Clinical Pharmacology·Damien DriotMaryse Lapeyre-Mestre
Jul 28, 2019·Drug and Therapeutics Bulletin·Harpreet SinghAlicja Wasilewski
Oct 2, 2019·Substance Use & Misuse·Alessandro E VentoFabrizio Schifano
Feb 28, 2020·Journal of Managed Care & Specialty Pharmacy·Nathan J PaulyPatricia R Freeman
May 28, 2020·Journal of Neuroscience Research·Taylor Boggess, W Christopher Risher
Aug 5, 2020·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Carrie Tamarelli, Avinash Hosanagar
Aug 5, 2020·Journal of Psychoactive Drugs·Mance E Buttram, Steven P Kurtz
Aug 29, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Staffan HäggJohan Ahlner
Jun 7, 2016·Addiction·Rachel V SmithSharon L Walsh
Apr 30, 2017·Clinical Drug Investigation·Alyssa M PeckhamDavid A Sclar
Sep 29, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alyssa M PeckhamDavid A Sclar
Dec 16, 2017·Expert Opinion on Investigational Drugs·Barbara J MasonFarhad Shadan
Apr 22, 2019·BMJ Case Reports·Harpreet SinghAlicja Wasilewski
Aug 29, 2018·Journal of Neonatal-perinatal Medicine·L DavidsonP Chandrasekharan
Mar 1, 2017·Academic Forensic Pathology·Grant FinlaysonKelly Quesnelle
Jun 28, 2020·Scientific Reports·Yusuf S AlthobaitiZahoor A Shah
Sep 6, 2020·British Journal of Clinical Pharmacology·Joanna HockenhullPaul I Dargan
Sep 13, 2020·Substance Use & Misuse·Mance E Buttram, Hilary L Surratt
May 12, 2017·Addiction·Abigail LyndonGraeme Henderson
Mar 3, 2020·Frontiers in Psychiatry·Massimo LanciaCristiana Gambelunghe
Mar 6, 2021·Substance Use & Misuse·Juuso PeltokorpiKaisa Riala
Mar 7, 2021·Pharmaceuticals·Yusuf S Althobaiti
Jan 28, 2021·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Nebojsa Nick KnezevicKenneth D Candido
Apr 17, 2021·Rapid Communications in Mass Spectrometry : RCM·Sarah J PhillipsHoward P Hendrickson
Nov 24, 2021·JAAPA : Official Journal of the American Academy of Physician Assistants·Meghan Migeon